The FDA has given Allergan the green light for its tear-inducing device, TrueTear. The neurostimulating device is a non-invasive and drug free temporary solution to increase tear production. This device is the first of its kind, and creating a breakthrough for treatment associated with dry eye disease. Adults who utilize the device will be able to increase tear flow and production by placing disposable tips into their nasal cavity. Read the full press release here.